FDA NDC
Depo-SubQ Provera
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0009-4709
- Proprietary name
- Depo-SubQ Provera
- Nonproprietary name
- medroxyprogesterone acetate
- Labeler
- Pharmacia & Upjohn Company LLC
- Dosage form
- INJECTION, SUSPENSION
- Strength
- 104 mg/.65mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted medroxyprogesterone acetate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.